Non-Complying Product definition

Non-Complying Product shall have the meaning set forth in Section 4.4(a).
Non-Complying Product shall have the meaning set forth in Section 4.4(a). información o datos técnicos o de otro tipo fabricación e ingeniería y dibujos técnicos, incluidos los derechos de propiedad exclusivos sobre cualquiera de los anteriores; y (b) las marcas registradas, solicitudes de registro de marcas, marcas sin registrar, imágenes comerciales, derechos de autor, conocimientos especializados, patentes, solicitudes de registro de patente y todas y cualesquiera disposiciones provisionales, divisiones, prolongaciones, prolongaciones parciales, prórrogas, sustituciones, renovaciones, registros, revalidaciones, reexpediciones o adiciones, incluyendo certificados complementarios de protección a las antedichas patentes y solicitudes de registro de patente y a todas las contrapartes extranjeras de esas patentes y solicitudes de registro de patente. 1.29. "Especificaciones de Empaque y Rotulado" tendrá el significado asignado en la Sección 2.4.(h). 1.30. "Defecto Latente" significa un defecto que hace que el Producto no se ajuste a las Especificaciones aplicables y que el Comprador pueda demostrar que existía en el momento de la entrega del Producto por parte de Pfizer y que no pudo ser detectado por el Comprador, su designado o su Personal mediante una inspección diligente en el momento de la entrega. 1.31. "Leyes" significan, colectivamente, todaslas leyes nacionales y locales aplicables, las leyes ordinarias, estatutos, ordenanzas, códigos, normas, reglamentos, órdenes, decretos u otros pronunciamientos de cualquier Gobierno o autoridad administrativa o judicial que tengan efecto xx xxx. 1.32. "Pérdidas" tendrá el significado asignadoen la Sección 8.1. 1.33. "Autorización de Comercialización" significa la autorización para comercializar el Producto o cualquier otro permiso con efectos similares otorgado por INVIMA- Instituto Nacional de Vigilancia de Medicamentos y Alimentos, según sea modificado o variado de tiempo en tiempo por INVIMA- Instituto Nacional de Vigilancia de Medicamentos y Alimentos, donde se permite introducir el Producto en el mercado en Colombia de acuerdo con la Ley. 1.34. "Producto No Conforme" tendrá el significado asignado en la Sección 4.4.(a) CONFIDENTIAL- CONFIDENCIAL
Non-Complying Product has the meaning set forth in Article I.6.14; ‘Notification’ (or ‘notify’): form of communication between the parties made in writing including by electronic means;

Examples of Non-Complying Product in a sentence

  • This inoperability deduction shall be in addition to the “Price Deduction” assessed for not complying to one (or more) of the Non-Complying Product characteristics stated hereinafter.

  • The requesting agency may be required to sign a waiver of liability and responsibility on behalf of the Contractor.Bidder must maintain service facilities and have trained personnel qualified to service the product furnished at the using agency within 48 hours.7.4 Non-Complying Product – DeliveryDeliveries of fuel oil may be sampled at the Contractor’s loading point or at the point of delivery by a representative of the purchasing Agency’s personnel.

  • Confirma- tion/replication of this result in a larger sample would support the hypothesis that benign MS may have a distinct etiopathogenesis from the more severe MS forms.

  • If Fortinet determines that any Product unit does not conform to the warranties hereunder ("Non-Complying Product"), Fortinet or Fortinet’s designated agent shall return the Non-Complying Product to a location designated by Supplier through the agreed-upon RMA process in Section 15.

  • Supplier will provide an initial failure analysis of the Non-Complying Product within seven (7) business days, from its receipt.

  • Penalty Fees – Misuse and Non-Complying Product InvestigationsThe cost of misuse of the mark or non-complying product investigations can be $2500 for the first offence and $5000 for the second with the third resulting in termination of the listing.

  • In addition to Supplier’s obligation to conduct an initial failure analysis, Supplier agrees to segregate and separately report line and field returns by region and agree to provide a failure analysis of the defective Product unit to the component level within thirty (30) days of receipt of the Non-Complying Product.

  • That reduction shall be allocated to each priority proportionately.

  • GuidanceRefer to Part 6.8 Non-Complying Product and Recall for further information on managing non-compliances and recall of affected products.

  • Wilkins (1992) affords the same classification to apples, oranges, gourmet coffee and coal, as to meat.


More Definitions of Non-Complying Product

Non-Complying Product definition is set forth in Section 9.1 of this Agreement.
Non-Complying Product shall have the meaning set forth in Section 4.4(a). información o datos técnicos o de otro tipo fabricación e ingeniería y dibujos técnicos, incluidos los derechos de propiedad exclusivos sobre cualquiera de los anteriores; y (b) las marcas registradas, solicitudes de registro de marcas, marcas sin registrar, imágenes comerciales, derechos de autor, conocimientos especializados, patentes, solicitudes de registro de patente y todas y cualesquiera disposiciones provisionales, divisiones, prolongaciones, prolongaciones parciales, prórrogas, sustituciones, renovaciones, registros, reva lidaciones, reexpediciones o adiciones, incluyendo certifica dos complementarios de protección a las a ntedichas patentes y solicitudes de registro de patente y a todas las contrapartes extranjeras de esas patentes y solicitudes de registro de patente. 1.29. "Especificaciones de Empaque y Rotulado" tendrá el significado asignado en la Sección 2.4.(h). 1.30. "Defecto Latente" significa un defecto que hace que el Producto no se ajuste a las Especificaciones aplicables y que el Comprador pueda demostrar que existía en el momento de la entrega del Producto por parte de Pfizer y que no pudo ser detectado por el Comprador, su designado o su Personal mediante una inspección diligente en el momento de la entrega. 1.31. "Leyes" significan, colectivamente, todaslas leyes nacionales y loca les aplica bles, las leyes ordinarias, estatutos, ordenanzas, códigos, normas, reglamentos, órdenes, decretos u otros pronunciamientos de cualquier Gobierno o autoridad administrativa o judicial que tengan efecto xx xxx. 1.32. "Pérdidas" tendrá el significado asignadoen la Sección 8.1. 1.33. "
Non-Complying Product has the meaning set forth in Article I.6.14; “Non-EU Key Supply/ies”: means Key Supply/ies for which, at the time of production of the Vaccine pursuant to this PA, no supplier exists in the European Union that could provide the component, service and other input item from the territory of the EU. [***] ‘Notification’ (or ‘notify’): form of communication between the parties made in writing including by electronic means; ‘Participating Contractor Affiliate’: means an Affiliate of Pfizer or BioNTech as identified in Annex V; “PMS Experts” means, in relation to each Participating Member State, one (1) clinical expert employed by, or advising, such Participating Member State in connection with the COVID-19 pandemic, the identity of such individual to be communicated by the Commission to Contractor promptly following the Effective Date (it being understood that if Contractor expresses a reasonable objection to the identity of a PMS Expert, the relevant Participating Member State will suggest an alternative expert); [***]‘Product’: means the Vaccine; ‘Product Materials’: means all packaging materials and components needed for delivery of the Product; ‘Professional conflicting interest’: a situation in which the Contractor’s previous or ongoing professional activities affect its capacity to implement the PA or to perform a Vaccine Order Form to an appropriate quality standard; ‘Record’: means books, documents, and other data, of all matters relating to performance of obligations under this PA;
Non-Complying Product has the meaning set forth in Article I.6.14;

Related to Non-Complying Product

  • Drug Product means a specific drug in dosage form from a known source of manufacture, whether

  • cGMPs means current good manufacturing practices as described in Parts 210 and 211 of Title 21 of the United States’ Code of Federal Regulations, together with the latest FDA guidance documents pertaining to manufacturing and quality control practice, all as updated, amended and revised from time to time;

  • Finished Product means a cannabis product in its final form to be sold at a retail premises.

  • cGMP means current Good Manufacturing Practice as set forth in the United States Federal Food, Drug, and Cosmetic Act, as amended, and includes all rules and regulations promulgated by the FDA thereunder.

  • Drug Substance means an active ingredient that is intended to furnish pharmacological activity or other direct effect in the diagnosis, cure, mitigation, treatment, or prevention of disease or to affect the structure or any function of the human body, but does not include intermediates used in the synthesis of such ingredient.

  • Product Specifications means the specifications, features and/or terms of any "Contract" (as defined in the LME Rules) listed for trading on the LME, as described in the LME Rules;

  • Tobacco product manufacturer means an entity that after the date of enactment of this Act directly (and not exclusively through any affiliate):

  • Bulk drug substance means any substance that is represented for use, and that, when used in the

  • Product Specification means a product specification for a Medical Device set out in Schedule 2;

  • Manufacturing Know-How means, with respect to the Product or any Variant thereof, the technology, data, designs, processes, methods, specifications and other know-how used in connection with the formulation, manufacture, labeling, packaging, quality control, release testing, and production of the Product, and all ingredients used therein and portions thereof.

  • Non-Conforming Product means a Product that does not conform to the Supplier’s Warranties.

  • Aerosol product means a pressurized spray system that dispenses product ingredients by means of a propellant contained in a product or a product's container, or by means of a mechanically induced force. “Aerosol Product” does not include “Pump Spray.”

  • Product Manufacturer means the entity that assembles the component parts to manufacture the final Product;

  • Contract Manufacturer means a company that produces goods under contract for another company under the label or brand name of that company.

  • Manufacturing Site means a location where a manufacturing

  • medicinal product means any substance or combination of substances presented for treating or preventing disease in human beings or animals and any substance or combination of substances which may be administered to human beings or animals with a view to making a medical diagnosis or to restoring, correcting or modifying physiological functions in humans or in animals;

  • API means American Petroleum Institute.

  • Product Specific Terms means the terms applicable to a specific item of Licensed Software as set out in Schedule 2;

  • Finished Products means any one or more of the following petroleum oils, or a mixture or combination of these oils, to be used without further processing except blending by mechanical means:

  • Marijuana product means marijuana as defined in 50-32-101 and marijuana-infused products

  • Manufacturing Materials means parts, tools, dies, jigs, fixtures, plans, drawings, and information produced or acquired, or rights acquired, specifically to fulfill obligations set forth herein.

  • Bulk Product means Licensed Product supplied in a form other than Finished Product which can be converted into Finished Product.

  • Manufacturing Services means the manufacturing, quality control, quality assurance, stability testing, packaging, and related services, set forth in this Agreement, required to manufacture Product or Products from Active Materials and Components;

  • Clinical laboratory means a facility for the microbiological, serological, chemical, hematological, radiobioassay, cytological, immunohematological, pathological, or other examination of materials derived from the human body for the purpose of providing information for the diagnosis, prevention, or treatment of a disease or assessment of a medical condition.

  • NDA means a New Drug Application, as defined in the regulations promulgated by the United States Food and Drug Administration, or any foreign equivalent thereof.

  • Investigational Medicinal Product means the study drug or control material as defined in the Protocol.